BioAge scraps mid-stage trial of obesity drug, shares fall
09 Dec 2024 //
REUTERS
BioAge Labs Announces Pricing of Upsized Initial Public Offering
25 Sep 2024 //
GLOBENEWSWIRE
BioAge Labs Presents Preclinical Data for Azelaprag in Obesity
21 Jun 2024 //
BUSINESSWIRE